Castle Biosciences, Inc. - Common stock - Nakit Akışı (NASDAQ:CSTL) | MetaTrader

Tam grafiği aç Full chart

Financials

Genel Bakış Tablolar İstatistikler

Çeyreklik Yıllık

İşletme faaliyetlerinden elde edilen nakit 9.87 M-18.98 M-41.66 M-5.63 M64.87 M64.35 M 48.25 M Yatırım faaliyetlerinden elde edilen nakit -4.75 M-66.66 M-166.54 M-16.18 M-50.14 M-60.37 M -63.74 M Finansman faaliyetlerinden elde edilen nakit 305.89 M5.42 M1.51 M-2.3 M6.14 M-6.96 M -10.44 M Serbest nakit akışı 9.87 M-18.98 M-41.66 M-5.63 M64.87 M28.33 M 4.52 M

Haberler

BTIG, yüksek maliyetler nedeniyle Castle Biosciences hisse hedefini düşürdü

Castle Biosciences 1Ç 2026: Gelir beklentiyi aştı, rehberlik yükseltildi

Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Beats Revenue Estimates

Alkermes' Q1 Earnings & Revenues Beat Estimates, Stock Rises

OCGN Falls on Wider Q1 Loss Despite Strong Pipeline Progress Outlook

EDIT's Q1 Loss Narrower Than Expected, Pipeline in Focus

Repligen's Q1 Earnings & Revenues Beat Estimates, Stock Rises

JAZZ Stock Jumps as Q1 Earnings & Sales Surpass Expectations

BioMarin Q1 Earnings Miss, Sales Beat, '26 Revenue Guidance Raised

Krystal Biotech Q1 Earnings & Sales Beat Estimates, Pipeline in Focus

AXSM Q1 Loss Widens, Revenues Jump on Higher Auvelity Sales

Wall Street Analysts Predict an 85.15% Upside in Castle Biosciences (CSTL): Here's What You Should Know